An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis ; day:10 ; month:04 ; year:2023 ; extent:20
Advanced science ; (10.04.2023) (gesamt 20)
- Creator
-
Arif, Muhammad
Basu, Abhishek
Wolf, Kaelin M.
Park, Joshua K.
Pommerolle, Lenny
Behee, Madeline
Gochuico, Bernadette R.
Cinar, Resat
- DOI
-
10.1002/advs.202207454
- URN
-
urn:nbn:de:101:1-2023041115045129600066
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arif, Muhammad
- Basu, Abhishek
- Wolf, Kaelin M.
- Park, Joshua K.
- Pommerolle, Lenny
- Behee, Madeline
- Gochuico, Bernadette R.
- Cinar, Resat
Other Objects (12)
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Considerations for therapeutic intervention models of pulmonary fibrosis
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
Integrative multi‐omics analysis of intestinal organoid differentiation
Integrative Multi-omics Analysis of Childhood Aggressive Behavior
Nuclear MIRLET7D-induced inhibition of EP300 as therapeutic approach for idiopathic pulmonary fibrosis
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Considerations for therapeutic intervention models of pulmonary fibrosis
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
Integrative multi‐omics analysis of intestinal organoid differentiation
Integrative Multi-omics Analysis of Childhood Aggressive Behavior
Nuclear MIRLET7D-induced inhibition of EP300 as therapeutic approach for idiopathic pulmonary fibrosis
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Considerations for therapeutic intervention models of pulmonary fibrosis
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
Integrative multi‐omics analysis of intestinal organoid differentiation
Integrative Multi-omics Analysis of Childhood Aggressive Behavior